Swiss National Bank maintained its position in shares of Vitamin Shoppe, Inc (NYSE:VSI) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 38,300 shares of the specialty retailer’s stock at the end of the first quarter. Swiss National Bank owned about 0.17% of Vitamin Shoppe worth $772,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the company. Comerica Bank raised its stake in shares of Vitamin Shoppe by 37.8% in the first quarter. Comerica Bank now owns 35,339 shares of the specialty retailer’s stock worth $689,000 after buying an additional 9,685 shares during the last quarter. First Trust Advisors LP acquired a new stake in Vitamin Shoppe during the first quarter valued at approximately $549,000. LSV Asset Management raised its stake in Vitamin Shoppe by 109.4% in the first quarter. LSV Asset Management now owns 76,648 shares of the specialty retailer’s stock valued at $1,544,000 after buying an additional 40,048 shares during the last quarter. Great West Life Assurance Co. Can raised its stake in Vitamin Shoppe by 7.7% in the first quarter. Great West Life Assurance Co. Can now owns 35,279 shares of the specialty retailer’s stock valued at $707,000 after buying an additional 2,513 shares during the last quarter. Finally, Canada Pension Plan Investment Board raised its stake in Vitamin Shoppe by 111.3% in the first quarter. Canada Pension Plan Investment Board now owns 131,200 shares of the specialty retailer’s stock valued at $2,644,000 after buying an additional 69,100 shares during the last quarter.

Shares of Vitamin Shoppe, Inc (NYSE VSI) traded down 1.99% during trading on Monday, hitting $9.85. 363,159 shares of the company were exchanged. The firm’s 50-day moving average price is $11.06 and its 200 day moving average price is $16.58. Vitamin Shoppe, Inc has a 12 month low of $9.75 and a 12 month high of $28.94. The firm has a market capitalization of $228.16 million, a PE ratio of 12.68 and a beta of 0.68.

Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings data on Wednesday, May 10th. The specialty retailer reported $0.37 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.21. Vitamin Shoppe had a return on equity of 9.35% and a net margin of 1.43%. The business had revenue of $316.90 million during the quarter, compared to analysts’ expectations of $325.71 million. During the same quarter in the previous year, the company posted $0.67 EPS. The company’s revenue was down 5.9% compared to the same quarter last year. On average, equities research analysts expect that Vitamin Shoppe, Inc will post $1.57 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/07/swiss-national-bank-has-772000-stake-in-vitamin-shoppe-inc-nysevsi-updated-updated-updated.html.

Several equities research analysts recently commented on the stock. Morgan Stanley raised shares of Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 price objective on the stock in a research note on Thursday, May 11th. Gabelli cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Thursday, May 11th. ValuEngine cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. BidaskClub cut shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Finally, Zacks Investment Research cut shares of Vitamin Shoppe from a “hold” rating to a “strong sell” rating in a report on Saturday, May 13th. Two equities research analysts have rated the stock with a sell rating and seven have issued a hold rating to the company. Vitamin Shoppe has a consensus rating of “Hold” and an average price target of $21.50.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Stock Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related stocks with our FREE daily email newsletter.